Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego W Lodzi SPZOZ

At Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego W Lodzi SPZOZ, a major focus is cardiovascular disease and heart failure, with studies spanning acute and chronic forms of the condition as well as related kidney and inflammatory complications. This work is aimed at testing new treatment approaches and improving outcomes for people living with complex heart disease.

• Heart failure with preserved, mildly reduced, or reduced ejection fraction
• Acute myocardial infarction and atherosclerotic cardiovascular disease
• Cardiorenal disease, systemic inflammation, and treatment response

These trials explore whether new therapies can reduce hospitalizations, lower cardiovascular risk, and improve symptoms and heart function.

Research at this hospital clinic also includes chronic kidney disease and conditions where kidney problems overlap with heart disease and high blood pressure. The studies are designed to evaluate whether emerging treatments can slow disease progression and better control inflammation-driven illness.

• Chronic kidney disease with hypertension or systemic inflammation
• Heart failure complicated by impaired kidney function
• Inflammation-related cardiovascular and renal risk

Overall, this area of research is focused on finding safer and more effective ways to protect both kidney and cardiovascular health.

The site contributes to respiratory disease research, especially in chronic obstructive pulmonary disease and progressive pulmonary fibrosis. These studies aim to assess whether new therapies can reduce worsening symptoms, limit flare-ups, and preserve lung function over time.

• Chronic obstructive pulmonary disease and chronic bronchitis
• Progressive pulmonary fibrosis
• Long-term symptom control and lung function preservation

This research supports the search for better treatment options in chronic lung conditions that can significantly affect daily life.

Another important area is immune system disease, including inflammatory skin and muscle disorders. Trials here examine whether new therapies can improve disease control, reduce active inflammation, and support sustained remission in conditions that are often difficult to manage.

• Bullous pemphigoid
• Moderate-to-severe plaque psoriasis
• Polymyositis and dermatomyositis

These studies are focused on testing treatment effectiveness and helping patients achieve better symptom relief and disease stability.

Clinical research at the site also extends to nervous system diseases and musculoskeletal disorders, reflecting a broad interest in conditions that affect movement, strength, and long-term function. The studies are intended to evaluate new options that may slow progression or improve recovery and quality of life.

• Primary progressive multiple sclerosis
• Total knee arthroplasty and prevention of venous thromboembolism
• Musculoskeletal and neural functional outcomes

This line of research combines treatment innovation with practical goals such as better postoperative protection and improved disability management.